Translational Biomarkers and Ex Vivo Models of Joint Tissues as a Tool for Drug Development in Rheumatoid Arthritis

OBJECTIVE: Rheumatoid arthritis (RA) is a chronic and degenerative autoimmune joint disease that leads to disability, reduced quality of life, and increased mortality. Although several synthetic and biologic disease‐modifying antirheumatic drugs are available, there is still a medical need for novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Kjelgaard‐Petersen, Cecilie F., Platt, Adam, Braddock, Martin, Jenkins, Martin A., Musa, Kishwar, Graham, Emma, Gantzel, Thorbjørn, Slynn, Gillian, Weinblatt, Michael E., Karsdal, Morten A., Thudium, Christian S., Bay‐Jensen, Anne‐C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174937/
https://www.ncbi.nlm.nih.gov/pubmed/29669391
http://dx.doi.org/10.1002/art.40527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174937/
https://www.ncbi.nlm.nih.gov/pubmed/29669391
http://dx.doi.org/10.1002/art.40527

Ejemplares similares